USP11 and prostate cancer: Depletion of USP11 enhanced growth, invasion, and glucose and glutamine metabolism in ERG-negative 22Rv1 human prostate cancer cells stably overexpressing ERG (22Rv1ERG) (Supplementary Fig. 7a–c).